Validation of a Non-invasive Hemodynamic Monitor (NexFin) in Pregnant Women

Oslo University Hospital20 enrolled

Overview

Blood pressure and cardiac output can be measured invasively in pregnant women. Non-invasive monitoring devices are desirable, but until now, no equipment has proven validity. This study aims at validating the non-invasive monitoring device NexFin (second generation Finometer) in pregnant women.

Validation will be a direct beat-to-beat comparison of data from NexFin and the invasive measurements of blood pressure and calibrated cardiac output as an integrated part of LiDCO Plus. Both comparison of absolute values and the two different devices trending abilities will be analyzed.

Study Type

OBSERVATIONAL

Enrollment

Conditions

Hemodynamic Changes in Pregnancy

Eligibility

Sex: FEMALEMin age: 18 YearsMax age: 50 Years

Medical Language ↔ Plain English

Inclusion Criteria: * Healthy singleton pregnancies at term scheduled for cesarean delivery Exclusion Criteria: * Twins, or multiple gestation, pre-eclampsia, gestational hypertension * Reynaud phenomenon

Locations (1)

Oslo University Hospital

Oslo, Norway

Outcomes

Primary Outcomes

Systolic blood pressure

Comparison of beat-to-beat data

Time frame: 15 minutes

Secondary Outcomes

Cardiac output

Comparing beat-to-beat data of cardiac output

Time frame: 15 minutes

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.